These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 8998091

  • 1. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation.
    Innes GD, Vertesi L, Dillon EC, Metcalfe C.
    Ann Emerg Med; 1997 Jan; 29(1):126-34. PubMed ID: 8998091
    [Abstract] [Full Text] [Related]

  • 2. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin.
    Schreck DM, Rivera AR, Tricarico VJ.
    Ann Emerg Med; 1997 Jan; 29(1):135-40. PubMed ID: 8998092
    [Abstract] [Full Text] [Related]

  • 3. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ, Pfitzner P.
    Med Klin (Munich); 1996 Oct 15; 91(10):617-25. PubMed ID: 9019638
    [Abstract] [Full Text] [Related]

  • 4. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS, Ghali WA, Sanfilippo AJ, Moritz S, Abdollah H.
    Am Heart J; 2001 Aug 15; 142(2):E3. PubMed ID: 11479482
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
    Kerin NZ, Faitel K, Naini M.
    Arch Intern Med; 1996 Jan 08; 156(1):49-53. PubMed ID: 8526696
    [Abstract] [Full Text] [Related]

  • 6. Diltiazem, verapamil, and quinidine in patients with chronic atrial fibrillation.
    Ochs HR, Anda L, Eichelbaum M, Greenblatt DJ.
    J Clin Pharmacol; 1985 Apr 08; 25(3):204-9. PubMed ID: 3889076
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
    Cardiol J; 2009 Apr 08; 16(6):521-7. PubMed ID: 19950088
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
    Vainer J, Smíd J, Cepeláková H, Hapala J, Topinka I, Topolcan O.
    Vnitr Lek; 1989 Feb 08; 35(2):145-50. PubMed ID: 2711622
    [Abstract] [Full Text] [Related]

  • 9. [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
    Patten M, Koch HP, Sonntag F, Lüderitz B, Meinertz T.
    Z Kardiol; 1999 Mar 08; 88(3):185-94. PubMed ID: 10355069
    [Abstract] [Full Text] [Related]

  • 10. [Combination of quinidine and verapamil in auricular fibrillation].
    Sobrino JA, Maté I, Calvo L, Plaza I, Rico J, Moreno I, Mesa JM.
    Rev Esp Cardiol; 1989 Apr 08; 42(4):262-6. PubMed ID: 2781120
    [Abstract] [Full Text] [Related]

  • 11. [The use of digitalis glycosides in atrial fibrillation].
    Knez A, Haberl R, Steinbeck G.
    Z Kardiol; 1994 Apr 08; 83 Suppl 5():71-3. PubMed ID: 7846948
    [Abstract] [Full Text] [Related]

  • 12. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial).
    Halinen MO, Huttunen M, Paakkinen S, Tarssanen L.
    Am J Cardiol; 1995 Sep 01; 76(7):495-8. PubMed ID: 7653451
    [Abstract] [Full Text] [Related]

  • 13. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study.
    Waxman HL, Myerburg RJ, Appel R, Sung RJ.
    Ann Intern Med; 1981 Jan 01; 94(1):1-6. PubMed ID: 7447203
    [Abstract] [Full Text] [Related]

  • 14. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up.
    Zehender M, Hohnloser S, Müller B, Meinertz T, Just H.
    J Am Coll Cardiol; 1992 Apr 01; 19(5):1054-9. PubMed ID: 1552095
    [Abstract] [Full Text] [Related]

  • 15. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
    Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SP, Chang MS.
    J Intern Med; 1996 Mar 01; 239(3):253-60. PubMed ID: 8772625
    [Abstract] [Full Text] [Related]

  • 16. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
    Capucci A, Villani GQ, Aschieri D, Piepoli M.
    Int J Cardiol; 1999 Feb 28; 68(2):187-96. PubMed ID: 10189007
    [Abstract] [Full Text] [Related]

  • 17. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
    Fetsch T, Burschel G, Breithardt G, Engberding R, Koch HP, Lukl J, Trappe HJ, Treese N.
    Z Kardiol; 1999 Mar 28; 88(3):195-207. PubMed ID: 10355070
    [Abstract] [Full Text] [Related]

  • 18. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H, Bramann HU, Brisse B, Kuhs H.
    Med Klin; 1980 Feb 29; 75(5):196-8. PubMed ID: 6156393
    [Abstract] [Full Text] [Related]

  • 19. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):1001-9. PubMed ID: 16949494
    [Abstract] [Full Text] [Related]

  • 20. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G, Prevention of Atrial Fibrillation after Cardioversion Investigators.
    Eur Heart J; 2004 Aug 05; 25(16):1385-94. PubMed ID: 15302102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.